ZUG, Switzerland--(BUSINESS WIRE)--Galderma today announced that the New England Journal of Medicine has published full results from the phase III OLYMPIA 2 trial evaluating the efficacy and safety of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback